IL6 and colorectal carcinoma: A recent systematic review and meta-analysis has described a relationship between chronic inflammation, as measured by inflammatory circulating biomarkers (including C-reactive protein (CRP) and interleukin-6 (IL-6)) and an increased cancer incidence, including CRC [10].